• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗布鲁里溃疡病疫苗的研发前景。

Prospects for vaccine development against Buruli disease.

作者信息

Huygen Kris

机构信息

Pasteur Institute of Brussels, Mycobacterial Immunology, 642 Engelandstraat, B1180 Brussels, Belgium.

出版信息

Expert Rev Vaccines. 2003 Aug;2(4):561-9. doi: 10.1586/14760584.2.4.561.

DOI:10.1586/14760584.2.4.561
PMID:14711340
Abstract

Buruli disease, caused by Mycobacterium ulcerans, is an emerging infectious disease in tropical areas, particularly West Africa, which can cause deep necrotizing skin lesions, called Buruli ulcer. Buruli disease affects all age groups but about 50% of the cases are diagnosed in children. There is no evidence that Buruli disease is transmitted by direct person-to-person contact and it is very likely that contaminated water of rivers, swamps and lakes serves as the wildlife reservoir of M. ulcerans. This review briefly discusses the epidemiology, microbiology, pathology and treatment of the disease. It describes in detail the current knowledge of the immune response and focuses on the studies that have dealt with vaccination. Finally, experimental approaches for future immunoprophylaxis are discussed.

摘要

由溃疡分枝杆菌引起的布鲁里病是热带地区,特别是西非出现的一种传染病,可导致深部坏死性皮肤病变,称为布鲁里溃疡。布鲁里病影响所有年龄组,但约50%的病例在儿童中被诊断出来。没有证据表明布鲁里病通过人与人之间的直接接触传播,很可能河流、沼泽和湖泊中受污染的水是溃疡分枝杆菌的野生动物宿主。本文简要讨论了该病的流行病学、微生物学、病理学和治疗方法。详细描述了目前对免疫反应的认识,并重点介绍了与疫苗接种相关的研究。最后,讨论了未来免疫预防的实验方法。

相似文献

1
Prospects for vaccine development against Buruli disease.抗布鲁里溃疡病疫苗的研发前景。
Expert Rev Vaccines. 2003 Aug;2(4):561-9. doi: 10.1586/14760584.2.4.561.
2
Buruli ulcer (Mycobacterium ulcerans infection).布鲁里溃疡(溃疡分枝杆菌感染)。
Trans R Soc Trop Med Hyg. 2008 Oct;102(10):969-78. doi: 10.1016/j.trstmh.2008.06.006. Epub 2008 Jul 26.
3
[Buruli ulcer (Mycobacterium ulcerans infection); report from the International Congress in Yamoussoukro, Ivory Coast].[布氏溃疡(溃疡分枝杆菌感染);来自在科特迪瓦亚穆苏克罗举行的国际大会的报告]
Ned Tijdschr Geneeskd. 1999 Feb 6;143(6):312-6.
4
BCG vaccine effectiveness against Buruli ulcer: a case-control study in Benin.卡介苗对布氏杆菌溃疡的有效性:贝宁的一项病例对照研究。
Am J Trop Med Hyg. 2006 Oct;75(4):768-74.
5
Buruli ulcer.布鲁里溃疡
Hum Vaccin. 2011 Nov;7(11):1198-203. doi: 10.4161/hv.7.11.17751. Epub 2011 Nov 1.
6
Recombinant BCG Expressing Mycobacterium ulcerans Ag85A Imparts Enhanced Protection against Experimental Buruli ulcer.表达溃疡分枝杆菌Ag85A的重组卡介苗对实验性布鲁里溃疡具有更强的保护作用。
PLoS Negl Trop Dis. 2015 Sep 22;9(9):e0004046. doi: 10.1371/journal.pntd.0004046. eCollection 2015 Sep.
7
Buruli ulcer: Advances in understanding Mycobacterium ulcerans infection.布鲁里溃疡:分枝杆菌溃疡感染的研究进展。
Dermatol Clin. 2011 Jan;29(1):1-8. doi: 10.1016/j.det.2010.09.006.
8
Buruli ulcer: the third most common mycobacterial infection.布鲁里溃疡:第三常见的分枝杆菌感染。
CMAJ. 2002 Jun 25;166(13):1691.
9
Mycobacterium ulcerans infection.溃疡分枝杆菌感染
Lancet. 1999 Sep 18;354(9183):1013-8. doi: 10.1016/S0140-6736(99)01156-3.
10
[Mycobacterium ulcerans infection].溃疡分枝杆菌感染
Ann Med Interne (Paris). 2000 Sep;151(5):339-44.

引用本文的文献

1
Unlocking Opportunities for and .为 和 解锁机会。
ACS Infect Dis. 2024 Feb 9;10(2):251-269. doi: 10.1021/acsinfecdis.3c00371. Epub 2024 Jan 31.
2
IFN-γ and IL-5 whole blood response directed against mycolactone polyketide synthase domains in patients with infection.感染患者中针对分枝杆菌内酯聚酮合酶结构域的干扰素-γ和白细胞介素-5全血反应
PeerJ. 2018 Jul 31;6:e5294. doi: 10.7717/peerj.5294. eCollection 2018.
3
Combined inflammatory and metabolic defects reflected by reduced serum protein levels in patients with Buruli ulcer disease.
患有伯里溃疡病的患者血清蛋白水平降低,反映出其存在炎症和代谢缺陷的综合情况。
PLoS Negl Trop Dis. 2014 Apr 10;8(4):e2786. doi: 10.1371/journal.pntd.0002786. eCollection 2014 Apr.
4
Pathogenesis of skin ulcers: lessons from the Mycobacterium ulcerans and Leishmania spp. pathogens.皮肤溃疡的发病机制:从 Mycobacterium ulcerans 和 Leishmania spp. 病原体中得到的启示。
Cell Mol Life Sci. 2014 Jul;71(13):2443-50. doi: 10.1007/s00018-014-1561-z. Epub 2014 Jan 21.
5
Buruli ulcer disease: prospects for a vaccine.布鲁里溃疡病:疫苗的前景
Med Microbiol Immunol. 2009 May;198(2):69-77. doi: 10.1007/s00430-009-0109-6. Epub 2009 Feb 7.
6
Buruli ulcer: reductive evolution enhances pathogenicity of Mycobacterium ulcerans.布鲁里溃疡:还原性进化增强溃疡分枝杆菌的致病性。
Nat Rev Microbiol. 2009 Jan;7(1):50-60. doi: 10.1038/nrmicro2077.
7
Improved protective efficacy of a species-specific DNA vaccine encoding mycolyl-transferase Ag85A from Mycobacterium ulcerans by homologous protein boosting.通过同源蛋白加强,编码溃疡分枝杆菌(mycolyl-transferase Ag85A)的种特异性 DNA 疫苗的保护效力得到提高。
PLoS Negl Trop Dis. 2008 Mar 19;2(3):e199. doi: 10.1371/journal.pntd.0000199.
8
A booster vaccination with Mycobacterium bovis BCG does not increase the protective effect of the vaccine against experimental Mycobacterium ulcerans infection in mice.
Infect Immun. 2007 May;75(5):2642-4. doi: 10.1128/IAI.01622-06. Epub 2007 Feb 26.
9
Buruli ulcer (M. ulcerans infection): new insights, new hope for disease control.布氏杆菌溃疡(溃疡分枝杆菌感染):新见解,疾病控制新希望。
PLoS Med. 2005 Apr;2(4):e108. doi: 10.1371/journal.pmed.0020108. Epub 2005 Apr 26.